Table: begin end state 1 35 cytoplasmic 36 53 transmembrane 54 61 non-cytoplasmic 62 83 transmembrane 84 94 cytoplasmic 95 115 transmembrane 116 120 non-cytoplasmic 121 146 transmembrane 147 159 cytoplasmic 160 184 transmembrane 185 195 non-cytoplasmic 196 216 transmembrane 217 244 cytoplasmic 245 265 transmembrane 266 284 non-cytoplasmic 285 305 transmembrane 306 314 cytoplasmic 315 334 transmembrane 335 339 non-cytoplasmic 340 364 transmembrane 365 375 cytoplasmic 376 396 transmembrane 397 406 non-cytoplasmic 407 426 transmembrane 427 438 cytoplasmic
Input: >AO353_04405 MTTSTTYSDAVPAQPTNSTTRVATASFIGTAIEFYDFYVYATAAALVIGPVFFPQTSGTA QMLSAFLTFGIAFLARPLGSALFGHFGDRIGRKSTLVASLLLMGVCTTLIGVLPGYESIG AWAPILLCVLRFGQGLGLGGEWGGAALLATENAPKGKRAWFGMFPQLGPSIGFLAANGLF LTLAMTLNDEQFRSWGWRIPFLLSAVLVMVGLYVRLKLHETPVFANAMARQERVKIPLVE LFSQYWAPMLLGAAAMVVCYALFYISTVFSLSYGVSTLGYSRETFLGLLCFAVLFMAAAT PLSAWASDRFGRKPVLIIGGVLAILSGFTMEPLLTHGTTWGVALFLCIELFLMGVTFAPM GALLPELFPTRVRYTGASAAYNLGGIVGASAAPFFAQKLVAMGGLSWVGGYVSAAAVISL IAVLCLKETRHNDLNQVA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server